An interventional study of Smartwatch app to deliver binge-eating CBT strategies and Reminder control condition in Binge-Eating Disorder, sponsored by HabitAware Inc.. Not yet recruiting. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2023-04-28.
Sponsored by HabitAware Inc. · Not applicable, Interventional, and Other
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Binge-eating behavior is a central feature of eating disorders (e.g., binge-eating disorder, bulimia nervosa, anorexia nervosa-binge-eating/purging subtype) and is associated with higher rates of psychopathology, psychosocial impairment, medical comorbidity, and more severe obesity, all of which pose significant public health problems. Passive detection of binge eating episodes combined with a context-based reminder intervention could assist a patient in resuming healthy eating patterns. This study will test a smartwatch app that identifies binge eating behavior and provides CBT strategies to the patient after the episode.
233 studies on the registry are indexed under Binge-Eating Disorder; 51 are open to participants now.
This study's planned enrollment of 30 is below the median of 77 across 190 interventional studies indexed under Binge-Eating Disorder.
Browse Binge-Eating Disorder studies →HabitAware Inc. is the lead sponsor of 4 studies on the registry; 3 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
BMI (body mass index)
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
This group will receive the device which messages the participant after a passively detected binge-eating episode with CBT strategies.
Behavioral: Smartwatch app to deliver binge-eating CBT strategies
This group will receive a device that vibrates randomly throughout the day as a reminder not to binge eat.
Behavioral: Reminder control condition
Participants will receive a smartwatch with a pre-loaded app that will alert the participant to relevant binge-eating strategies based on their previous detected behavior.
Participants will receive a smartwatch that vibrates randomly, and will be instructed the vibration is a cue not to binge eat.
Percentage of patients in the HabitAware condition that report the treatment is acceptable.
Measured via post-treatment survey
Time frame: 8 weeks
Percentage of patients report that the binge episode detection is accurate
Measured via post-treatment survey
Time frame: 8 weeks
No study locations are listed for this record.
Start is estimated for Dec 2024; primary completion for Jun 2025, 6 months later.
Of 87 interventional studies with no phase under Binge-Eating Disorder, half reached primary completion within 25 months of starting (the median), counting those still running; a quarter within 16 and three quarters within 53. This study's planned 6 months is below that.
How these figures are worked out, and which studies are left out of them.
This study is not yet recruiting, as verified in Apr 2023. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
HabitAware Inc.